Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Interferon alpha association with neuromyelitis optica.
Cerebrospinal fluid immunological biomarkers associated with axonal damage in multiple sclerosis.
Systematic review and meta-analysis of pharmacological therapies for pain associated with postherpetic neuralgia and less common neuropathic conditions.
Constructing an adaptive care model for the management of disease-related symptoms throughout the course of multiple sclerosis--performance improvement CME.
An adaptive clinical trials procedure for a sensitive subgroup examined in the multiple sclerosis context.
Protein-protein interaction analysis highlights additional Loci of interest for multiple sclerosis.
What is the Real Fate of Vitamin D in Multiple Sclerosis?
Cognitive and psychiatric comorbidities in neuromyelitis optica.
Differences between users and non-users of complementary and alternative medicine among people with multiple sclerosis in Denmark: A comparison of descriptive characteristics.
High-Throughput Screening Platform for the Discovery of New Immunomodulator Molecules from Natural Product Extract Libraries.
Disutility of Illness for Caregivers and Families: A Systematic Review of the Literature.
Internal tremor in Parkinson's disease, multiple sclerosis, and essential tremor.
Efficacy and safety of alemtuzumab in multiple sclerosis and impact on nursing role.
Mental Health in Multiple Sclerosis Patients without Limitation of Physical Function: The Role of Physical Activity.
Pío del Río Hortega and the discovery of the oligodendrocytes.
Fish and egg specific immunoglobin e in multiple sclerosis patients.
"Microglial nodules" and "newly forming lesions" may be a Janus face of early MS lesions; implications from virus-induced demyelination, the Inside-Out model.
Deletion of caspase-8 in mouse myeloid cells blocks microglia pro-inflammatory activation and confers protection in MPTP neurodegeneration model.
The potential of epigenetic therapies in neurodegenerative diseases.
[Multiple sclerosis: socioeconomic effects and impact on quality of life].
Variables Related to Working Capability among Swiss Patients with Multiple Sclerosis-A Cohort Study.
Primary Position Upbeat Nystagmus during an Acute Attack of Multiple Sclerosis.
Investigation of Sequential Growth Factor Delivery during Cuprizone Challenge in Mice Aimed to Enhance Oligodendrogliogenesis and Myelin Repair.
The azetidine derivative, KHG26792 protects against ATP-induced activation of NFAT and MAPK pathways through P2X7 receptor in microglia.
Risk factors related to cardiovascular diseases and the metabolic syndrome in multiple sclerosis - a systematic review.
Pages
« first
‹ previous
…
543
544
545
546
547
548
549
550
551
…
next ›
last »